These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14699650)

  • 81. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
    Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
    [No Abstract]   [Full Text] [Related]  

  • 83. Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.
    Koscielny J; Kiesewetter H; Jörg I; Harenberg J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):299-307. PubMed ID: 17636192
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Keeping clots from mechanical heart valves.
    Harv Heart Lett; 2004 Mar; 14(7):7. PubMed ID: 15044144
    [No Abstract]   [Full Text] [Related]  

  • 85. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
    Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F
    Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
    Harper P; Monahan K; Baker B
    Intern Med J; 2005 Dec; 35(12):717-20. PubMed ID: 16313547
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.
    Kearon C; Ginsberg JS; Anderson DR; Kovacs MJ; Wells P; Julian JA; Mackinnon B; Demers C; Douketis J; Turpie AG; Van Nguyen P; Green D; Kassis J; Kahn SR; Solymoss S; Desjardins L; Geerts W; Johnston M; Weitz JI; Hirsh J; Gent M;
    J Thromb Haemost; 2004 May; 2(5):743-9. PubMed ID: 15099280
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Start warfarin treatment with provocation].
    Schnell R
    Lakartidningen; 2008 Oct 8-14; 105(41):2864-5. PubMed ID: 19013847
    [No Abstract]   [Full Text] [Related]  

  • 89. Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome.
    Crowther MA
    Thromb Res; 2004; 114(5-6):443-6. PubMed ID: 15507276
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Thrombosis in the antiphospholipid-antibody syndrome.
    Lockshin MD
    N Engl J Med; 1995 Sep; 333(10):667. PubMed ID: 7637739
    [No Abstract]   [Full Text] [Related]  

  • 91. [Oral anticoagulation--a good prophylaxis requiring check up].
    Arnesen H
    Tidsskr Nor Laegeforen; 2000 Jun; 120(16):1845. PubMed ID: 10925606
    [No Abstract]   [Full Text] [Related]  

  • 92. Genetics of warfarin response.
    Schillinger D
    N Engl J Med; 2008 Jun; 358(25):2741-2; author reply 2743-4. PubMed ID: 18565872
    [No Abstract]   [Full Text] [Related]  

  • 93. Taming killer clots.
    Comarow A
    US News World Rep; 2003 Mar; 134(7):56. PubMed ID: 12645476
    [No Abstract]   [Full Text] [Related]  

  • 94. Hepatic artery stenosis in antiphospholipid syndrome.
    Simoes JS; Davies B; Sangle SR; Davies RJ; D'Cruz DP
    Clin Appl Thromb Hemost; 2012 Jul; 18(4):432-3. PubMed ID: 22203036
    [No Abstract]   [Full Text] [Related]  

  • 95. Antiphospholipid Syndrome: Therapeutic Challenges.
    Alhasson H; Abdullah A; Salama A; Alweis R; Woodlock T
    Am J Ther; 2020; 27(3):e328-e330. PubMed ID: 31135387
    [No Abstract]   [Full Text] [Related]  

  • 96. Warfarin pharmacogenetics.
    Garcia DA; Hylek E
    N Engl J Med; 2009 Jun; 360(23):2474; author reply 2475. PubMed ID: 19494226
    [No Abstract]   [Full Text] [Related]  

  • 97. [Venous thromboembolism, warfarin and cancer--a well-known connection].
    Schulman S
    Lakartidningen; 2000 Oct; 97(41):4554. PubMed ID: 11107740
    [No Abstract]   [Full Text] [Related]  

  • 98. Warfarin and extractions.
    Brown AE
    Br Dent J; 2002 Dec; 193(12):668. PubMed ID: 12536981
    [No Abstract]   [Full Text] [Related]  

  • 99. Insufficient evidence supporting low-intensity warfarin for venous thromboembolism (VTE) prophylaxis.
    Cundiff DK
    MedGenMed; 2003 Jul; 5(3):2. PubMed ID: 14600639
    [No Abstract]   [Full Text] [Related]  

  • 100. Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases.
    Crétel E; Cacoub P; Huong DL; Gompel A; Amoura Z; Piette JC
    Lupus; 1999; 8(6):482-5. PubMed ID: 10483020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.